Imatinib Mesylate is used to treat chronic myelogenous leukemia, gastrointestinal stromal tumors and a number of other malignancies. It is sold under the brand names Gleevec. Reference standards of Imatinib Mesylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Imatinib Mesylate - API Standards [catalogue_number] => PA 09 28000 [category_ids] => ,80,71,78,70,82,117, [chemical_name] => [weight] => 589.71 [form] => C30H35N7O4S [cas] => 220127-57-1 [pslug] => 220127-57-1-imatinib-mesylate-api-pa0928000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37299 [offers_product_code] => PA 09 28000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28000
CAS :
Molecular Formula : C30H35N7O4S
Molecular Weight : 589.71
stdClass Object ( [pname] => Imatinib Mesylate - Impurity B [catalogue_number] => PA 09 28020 [category_ids] => ,80,79,71,78,70,82, [chemical_name] => [weight] => 380.49 [form] => C21H28N6O [cas] => 581076-65-5 [pslug] => 581076-65-5-imatinib-mesylate-impurity-b-pa0928020 [latest_product] => 0 [linkproducts] => 1 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37301 [offers_product_code] => PA 09 28020 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28020
Molecular Formula : C21H28N6O
Molecular Weight : 380.49
stdClass Object ( [pname] => Imatinib Mesylate - Impurity H [catalogue_number] => PA 09 28080 [category_ids] => ,80,71, [chemical_name] => [weight] => 121.14 [form] => C7H7NO [cas] => 350-03-8 [pslug] => 350-03-8-imatinib-mesylate-impurity-h-pa0928080 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37309 [offers_product_code] => PA 09 28080 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28080
Molecular Formula : C7H7NO
Molecular Weight : 121.14
stdClass Object ( [pname] => Imatinib Mesylate - Impurity J [catalogue_number] => PA 09 28100 [category_ids] => ,80,71,75,78,70,82, [chemical_name] => [weight] => 509.60 [form] => C29H31N7O2 [cas] => 571186-91-9 [pslug] => 571186-91-9-imatinib-mesylate-impurity-j-pa0928100 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 37312 [offers_product_code] => PA 09 28100 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 09 28100
Molecular Formula : C29H31N7O2
Molecular Weight : 509.60
stdClass Object ( [pname] => Imatinib Mesylate - Impurity G (Dihydrochloride) [catalogue_number] => PA 09 28071 [category_ids] => ,71,70, [chemical_name] => [weight] => 173.08 [form] => C5H14Cl2N2 [cas] => 34352-59-5 [pslug] => 34352-59-5-imatinib-mesylate-impurity-g-dihydrochloride-pa0928071 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 09 28071
Molecular Formula : C5H14Cl2N2
Molecular Weight : 173.08
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
